Potentiation of the antimalarial agent rufigallol.
AUTOR(ES)
Winter, R W
RESUMO
We have discovered a remarkable synergistic antimalarial interaction between rufigallol and the structurally similar compound exifone. The synergistic effects were produced in chloroquine-susceptible and chloroquine-resistant clones of Plasmodium falciparum. The degree of potentiation as estimated by standard isobolar analysis was approximately 60-fold for experiments initiated with asynchronous parasites. The most pronounced synergism was observed in experiments with synchronized trophozoite-infected erythrocytes, in which the degree of synergy was at least 300-fold. While the mechanism underlying this drug potentiation remains unresolved, it is hypothesized that rufigallol acts in pro-oxidant fashion to produce oxygen radicals inside parasitized erythrocytes. These radicals would attack exifone, thereby initiating its transformation into a more potent compound, a xanthone.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=163340Documentos Relacionados
- Potentiation of an antimalarial oxidant drug.
- Crystal and molecular structure of the antimalarial agent enpiroline.
- Effects of α-Thalassemia on Pharmacokinetics of the Antimalarial Agent Artesunate
- Iron-dependent free radical generation from the antimalarial agent artemisinin (qinghaosu).
- X-ray crystal structure of the antimalarial agent (-)-halofantrine hydrochloride supports stereospecificity for cardiotoxicity.
